Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126264071 | 12626407 | 1 | I | 201410 | 20160729 | 20160805 | 20160805 | EXP | ES-JNJFOC-20160800143 | JANSSEN | 59.70 | YR | A | F | Y | 93.00000 | KG | 20160805 | MD | ES | ES |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126264071 | 12626407 | 1 | SS | STELARA | USTEKINUMAB | 1 | Subcutaneous | 0, 4, 12 WEEKS | N | 0 | 45 | MG | SOLUTION FOR INJECTION | ||||||
| 126264071 | 12626407 | 2 | SS | STELARA | USTEKINUMAB | 1 | Subcutaneous | REINTRODUCED 1 DOSE??0,4,12 WEEK | N | 0 | 45 | MG | SOLUTION FOR INJECTION | ||||||
| 126264071 | 12626407 | 3 | PS | STELARA | USTEKINUMAB | 1 | Subcutaneous | N | 125261 | 45 | MG | SOLUTION FOR INJECTION | |||||||
| 126264071 | 12626407 | 4 | C | OMEPRAZOLE. | OMEPRAZOLE | 1 | Unknown | 0 | UNSPECIFIED | ||||||||||
| 126264071 | 12626407 | 5 | C | METFORMIN | METFORMIN HYDROCHLORIDE | 1 | Unknown | 0 | UNSPECIFIED | ||||||||||
| 126264071 | 12626407 | 6 | C | PENTOXIFILINA | PENTOXIFYLLINE | 1 | Unknown | 0 | UNSPECIFIED | ||||||||||
| 126264071 | 12626407 | 7 | C | CLOBETASOL | CLOBETASOL | 1 | Unknown | 0 | UNSPECIFIED | ||||||||||
| 126264071 | 12626407 | 8 | C | FESOTERODINE | FESOTERODINE | 1 | Unknown | 0 | UNSPECIFIED | ||||||||||
| 126264071 | 12626407 | 9 | C | QUETIAPINE. | QUETIAPINE | 1 | Unknown | 0 | UNSPECIFIED | ||||||||||
| 126264071 | 12626407 | 10 | C | CLOTIAPINE | CLOTHIAPINE | 1 | Unknown | 0 | UNSPECIFIED | ||||||||||
| 126264071 | 12626407 | 11 | C | LORAZEPAM. | LORAZEPAM | 1 | Unknown | 0 | UNSPECIFIED | ||||||||||
| 126264071 | 12626407 | 12 | C | TRAZODONE | TRAZODONE HYDROCHLORIDE | 1 | Unknown | 0 | UNSPECIFIED | ||||||||||
| 126264071 | 12626407 | 13 | C | VORTIOXETINE | VORTIOXETINE | 1 | Unknown | 0 | UNSPECIFIED | ||||||||||
| 126264071 | 12626407 | 14 | C | BETAHISTINE | BETAHISTINE | 1 | Unknown | 0 | UNSPECIFIED |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126264071 | 12626407 | 1 | Psoriasis |
| 126264071 | 12626407 | 2 | Psoriasis |
| 126264071 | 12626407 | 3 | Psoriasis |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 126264071 | 12626407 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126264071 | 12626407 | Inappropriate schedule of drug administration | |
| 126264071 | 12626407 | Mental disorder | |
| 126264071 | 12626407 | Off label use |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 126264071 | 12626407 | 1 | 20140306 | 201410 | 0 | |
| 126264071 | 12626407 | 2 | 20151204 | 0 | ||
| 126264071 | 12626407 | 3 | 20160617 | 0 |